NCT04196725

Brief Summary

Participants with lymphedema secondary to cancer treatment will participate in a two week rehabilitation programme focusing on physical therapy treatment and a two week programme focusing on physical exercise. The purpose is to assess the effect of the rehabilitation programmes on lymphedema and measures of physical performance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 11, 2019

Completed
25 days until next milestone

Study Start

First participant enrolled

December 6, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 12, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 4, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 4, 2020

Completed
Last Updated

May 20, 2020

Status Verified

December 1, 2019

Enrollment Period

4 months

First QC Date

November 11, 2019

Last Update Submit

May 18, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Lymphedema

    Ratio of the volume of affected limb vs volume of nonaffected limb measured by DXA

    Change from before to the end of each of the two week rehabilitation programmes.

Secondary Outcomes (9)

  • Maximal strength

    Measured immediately before and at the end of each of the two week rehabilitation programmes.

  • Balance

    Measured immediately before and at the end of each of the two week rehabilitation programmes.

  • Flexibility in hip and back

    Measured immediately before and at the end of each of the two week rehabilitation programmes.

  • Flexibility in shoulder

    Measured immediately before and at the end of each of the two week rehabilitation programmes.

  • Test of physical functionality

    Measured immediately before and at the end of each of the two week rehabilitation programmes.

  • +4 more secondary outcomes

Study Arms (3)

Physical therapy treatment

EXPERIMENTAL
Other: Physical therapy treatment

Lifestyle treatment

EXPERIMENTAL
Behavioral: Lifestyle treatment

Control

NO INTERVENTION

Parallel control group, not undertaking any treatment and not part of the cross-over design

Interventions

Two weeks rehabilitation programme focusing on physical therapy treatment, e.g. manual lymphatic drainage and compression bandaging

Physical therapy treatment

Two weeks rehabilitation programme focusing on physical activity

Lifestyle treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Secondary lymphedema in arm or/and leg related to cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inland Norway University of Applied Sciences

Lillehammer, Norway

Location

MeSH Terms

Conditions

LymphedemaNeoplasm Metastasis

Interventions

Physical Therapy Modalities

Condition Hierarchy (Ancestors)

Lymphatic DiseasesHemic and Lymphatic DiseasesNeoplastic ProcessesNeoplasmsPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: 26 participants will be enrolled in the cross over design consisting of two different rehabilitation programme. In addition there will be a parallel control group with 10 participants not participating in any of the rehabilitation programmes.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 11, 2019

First Posted

December 12, 2019

Study Start

December 6, 2019

Primary Completion

April 4, 2020

Study Completion

April 4, 2020

Last Updated

May 20, 2020

Record last verified: 2019-12

Locations